1 / 4

Associations Between Aldosterone Antagonist Therapy and Risks of Mortality

Associations Between Aldosterone Antagonist Therapy and Risks of Mortality. Mortality. Hernandez HS. JAMA . 2012;308(20):2097-2107. Associations Between Aldosterone Antagonist Therapy and Risks of Cardiovascular readmission. Cardiovascular readmission.

guy-glover
Télécharger la présentation

Associations Between Aldosterone Antagonist Therapy and Risks of Mortality

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Associations Between AldosteroneAntagonist Therapy and Risks of Mortality Mortality Hernandez HS. JAMA. 2012;308(20):2097-2107

  2. Associations Between AldosteroneAntagonist Therapy and Risks of Cardiovascularreadmission Cardiovascularreadmission Hernandez HS. JAMA. 2012;308(20):2097-2107

  3. Associations Between AldosteroneAntagonist Therapy and Risks ofHeartfailurereadmission Heartfailurereadmission Hernandez HS. JAMA. 2012;308(20):2097-2107

  4. Associations Between AldosteroneAntagonist Therapy and Risks of Hyperkalemiareadmission Hyperkalemiareadmission Hernandez HS. JAMA. 2012;308(20):2097-2107

More Related